Csaba Pazmany

Senior Director Of Business Development at Evozyne

Csaba Pazmany, MS, MBA has an extensive work experience in the biotechnology and pharmaceutical industry. Csaba is currently serving as the Senior Director of Business Development at Evozyne, where they apply AI/ML to globally engineer proteins and identifies best-in-class therapeutics. Previously, they held the position of Director of Business Development at Cytovance Biologics, where they provided full-service manufacturing solutions for therapeutic products. Csaba also served as the Director of Business Development and Corporate Strategy at Abveris, establishing corporate partnerships and implementing synergistic technologies. Prior to that, they worked as an Associate Director at LakePharma, Inc., managing strategic partnerships and establishing a biorepository business unit. Csaba also worked as a Business Advisor, providing strategic business guidance and technical expertise to venture launch projects. Earlier in their career, they held various positions at Juno Therapeutics, X-BODY Biosciences, Dyax Corp, Genzyme, and Pierce Biotechnology, where they gained expertise in protein sciences, project/program management, protein production and purification, and research and development. Csaba Pazmany holds a Master of Science degree and a Master of Business Administration degree.

Csaba Pazmany has a Bachelor's degree in Bioengineering and Biomedical Engineering from Boston University. Csaba also holds a Bachelor's degree in the same field from the same university. Additionally, they have a Master's degree in Biotechnology from Worcester Polytechnic Institute and a Master's degree in Business Administration (MBA) from the Questrom School of Business, Boston University.

Location

Boston, United States

Links

Previous companies


Org chart


Teams


Offices

This person is not in any offices


Evozyne

1 followers

Evozyne combines evolution and deep learning technology to create highly functional novel proteins — Natural Machines™ — to solve longstanding challenges in therapeutics and sustainability. By amplifying a protein’s function based on the rules of nature, we address complex, high-impact problems. From developing life-changing patient treatments to making carbon capture a reality, Evozyne is committed to making a healthier, more sustainable world.


Industries

Employees

51-200

Links